Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertension

Blood Pressure

Volumn 8, Issue 3, 1999, Pages 184-191

  Os, Ingrid ^a   Stokke, Hans Petter ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Nordsia Health Center   (Norway)

Author keywords

Blood pressure; Doxazosin; Doxazosin GITS; Hypertension; Mild hypertension; Responders; Tolerability

Indexed keywords

DOXAZOSIN;

ADULT; AGED; ARTICLE; ASTHENIA; BLOOD PRESSURE MEASUREMENT; BORDERLINE HYPERTENSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TITRIMETRY;

EID: 0032728650     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370599439724     Document Type: Article

References (15)

1. Fulton B, Wagstaff AJ, Sorkin EM. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostate hyperplasia (published errata appear in Drugs. 1995; 49: 554, Drugs. 1995; 50: 559]. Drugs 1995; 49: 295-320.
2. Leren P. The cardiovascular effects of alpha-receptor blocking agents. J Hypertens 1992; 10 (Suppl 3): S11-4.
3. Lund-Johansen P, Omvik P. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect. Cardiovasc Drugs Ther 1991; 5: 605-15
4. Neaton JD, Grimm RH Jr, Prineas RJ, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Research Group. JAMA 1993; 270: 713-24.
5. Talseth T, Westlie L, Daae L. Doxazosin and atenolol as monotherapy in mild and moderate hypertension: a randomized parallel study with a three-year follow-up. Am Heart J 1991; 121: 280-85.
6. Wessels F. Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension. Am Heart J 1991; 121: 99-303.
7. Donner A. Approaches to sample size estimation in the design of clinical trials - a review. Stat Med 1984; 3: 199-214.
8. Eri LM, Wahlqvist R, Tveter KJ. Diagnosis and treatment of benign prostatic hyperplasia in general practice. Tidsskr Nor Laegeforen 1996; 116: 3240-4.
9. Gillenwater JY, Conn L, Chrysant SG, et al, for the Multicenter Study Group. Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: a double-blind, placebo-controlled, dose-response multicenter study. J Urol 1995; 54: 110-5.
10. Lepor H. Role of long-acting selective alpha-1 blockers in the treatment of benign prostatic hyperplasia. Urol Clin North Am 1990; 17: 651-9.
11. Chung M, Vashi V, Puente J, Sweeney M. Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation. Br J Clin Pharmacol 1999.
12. Collett D. Modelling binary data. 1st edn. London: Chapman & Hall, 1991.
13. Armitage P, Berry G. Statistical methods in medical research. 2nd edn. Oxford: Blackwell Scientific Publications, 1987.
14. Fienberg SE. The analysis of cross-classified categorical data. 1st edn. Cambridge, Mass: MIT Press, 1977.
15. SAS/STAT User's Guide, Version 6. 4th edn. Cary, NC: SAS Institute Inc, 1990.